Comment on Offidani et al, page [2159][1], and comment on Mateos et al, page [2165][2] Complete response has been a primary end point in many cancer therapy trials—including the two reported in this issue for elderly patients with multiple myeloma—but does not per se translate into survival
No takes yet. Share an insight, caveat, or question.
Barlogie et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: